Lara Hilal

Papers

Total Citations

H-Index

About

Dr. Lara Hilal is a leading oncologist whose research focuses on optimizing treatment strategies for head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). Her most cited work, "Patient Selection for Surgery vs Radiotherapy for Early Stage Oropharyngeal Cancer" (2021, 12 citations), provides critical guidance on choosing between transoral robotic surgery (TORS) and intensity modulated radiation therapy (IMRT) for early-stage disease. This study highlights the comparable survival outcomes of both modalities while emphasizing the importance of patient-specific factors in treatment selection. Dr. Hilal’s contributions have helped refine clinical decision-making in head and neck oncology, offering clarity on when surgery or radiotherapy may be most appropriate. Her work bridges the gap between surgical and radiation oncology, promoting personalized care that balances efficacy with quality of life. With a growing citation impact, Dr. Hilal is recognized for advancing evidence-based approaches that directly influence patient management. Her research continues to shape the landscape of head and neck cancer treatment, making her a valuable resource for clinicians and researchers seeking to improve outcomes in this challenging field.